Home / 3D Bioprinting / Ozbolat Lab at Penn State Uses CELLINK Bioprinter to Advance Cartilage Regeneration

Ozbolat Lab at Penn State Uses CELLINK Bioprinter to Advance Cartilage Regeneration

As recently featured in a major TV news story (see video above) Dr. Ozbolat is working on advancing regenerative medicine and specifically the regeneration of implantable, bioprinted cartilage grafts. Ozbolat Lab has been conducting extensive research in this segment and is using a CELLINK Inkredible+ bioprinter to do it.

Professor Ozbolat is an Associate Professor of Engineering Science and Mechanics Department, Biomedical Engineering Department, and a faculty member of the Huck Instiututes of the Life Sciences, Materials Research Institute, Center for Neural Engineering, Center for Innovative Materials Processing through Direct Digital Deposition, and Center for Research on Advanced Fiber Technologies at Penn State University.

Previously, he was a faculty member of The University of Iowa, Iowa City, IA and spearheaded Advanced Manufacturing Technology Group and the Biomanufacturing Laboratory. He received his Ph.D. in tissue  engineering  from the University at Buffalo (SUNY) in Buffalo, New York, and dual B.S. degrees in Mechanical Engineering and in Industrial Engineering from Middle East Technical University, Ankara, Turkey.

Dr. Ozbolat’s major research thrust is in the area of Bioprinting and Tissue Engineering. His research on bioprinting for tissue and organ fabrication has been published in several high quality of venues, received various awards and featured in national and international media, broadcast TVs  and press numerous times. He frequently give talks at national and international forums, conferences and seminars and organizes demonstrations and events to public and youth to encourage participation of future’s engineers in medicine, engineering and science. His technology spun off two start-up companies.

Ozbolat Lab at the Penn State University focuses on establishing cutting-edge bioprinting science and technology for various areas in regenerative medicine. The research group has been engaged in several projects sponsored by governmental agencies, private corporations, local agencies and industry. The current research interests include:

1. Bioprinting of pancreatic organ for type-I diabetes
2. Vascular and vascularized tissue printing and angiogenesis
3. In-situ composite tissue printing
4. Scaffold-free tissue printing
5. Bioprinting of organ-a-chip models
6. Development of new bioinks for advanced tissue printing
7. Development of new bioprinter technologies
8. Understanding physics of bioprinting processes
9. Bioprinting tumor models for immune-cancer cell interactions.

About 3D Printing Media Network

Check Also

12 Chinese Resellers of the EnvisionTEC 3D Bioplotter Meet at GDI

On 10th August, Shanghai Graphic Digital Information Co., Ltd. (GDI) and EnvisionTEC GmbH co-organized the …

Leave a Reply

Your email address will not be published.